Open tender · Germany · Contract notice
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Palonosetron (ausschl. Dafo. WKA), ATC A04AA05 f. d. Z. 01.08.2026 - 31.07.2028 (zzgl. V.-Option 1x12 Monate)
DAK-Gesundheit in Germany is inviting bids for “Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Palonosetron (ausschl. Dafo. WKA), ATC A04AA05 f. d. Z”. Bids close on 5 June 2029.
The work
Non-exclusive discount agreement for Palonosetron (ATC A04AA05) for DAK-Gesundheit from 01.08.2026 to 31.07.2028 with a 12-month option.
- Agreement for Palonosetron in WKA form
- Contractual terms of DAK-Gesundheit
- Submission of filled annexes 1 and 2
Key facts
- Contract period
- 01.08.2026 to 31.07.2028 (with 12-month extension option)
- Evaluation
- Selection based on application letter
What it takes to qualify
Worth a closer look
- § 130a Abs. 8 SGB V
- § 4. Teils des GWB
- Zulassungsmodells
- Deutsche Vergabeportal
- Offene Verfahren
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- Angebotsschreibenelectronic offer per email
- Anerkennung der vertraglichen Maßgabensigned contract with name or company stamp
- Anlage 1filled out and submitted per email
- Anlage 2Excel file with drug list sent per email